Ciamexon
Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration.
Product Specifications
CAS Number
75985-31-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
203.24
Molecular Formula
C11H13N3O
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
I0650-01J-PE 100 µL
ICOS Ligand (CD275, Inducible T cell Co-stimulator Ligand, B7-H2, B7 Homolog 2, B7-like Protein GL50, B7 Related Protein 1, B7H2, B7RP-1, B7RP1, GL50, ICOS LG, ICOSLG, KIAA0653, LICOS, Transmembrane Protein B7-H2 ICOS Ligand) (PE) discontinued
Sign In for Pricing
View Details 
K7526307 1.0 µg DNA
Scn10a sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
Sign In for Pricing
View Details LV742767 1.0 µg DNA
RHOA-IT1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details P9102-91L4-APC 200 µL
PRKAR1B, NT (cAMP-dependent Protein Kinase Type I-beta Regulatory Subunit) (APC) discontinued
Sign In for Pricing
View Details 